Consensus document on the progression and treatment response criteria in gastroenteropancreatic neuroendocrine tumors
Clin. transl. oncol. (Print)
; 20(12): 1522-1528, dic. 2018. tab
Article
en En
| IBECS
| ID: ibc-173758
Biblioteca responsable:
ES1.1
Ubicación: BNCS
ABSTRACT
Purpose:
Gastroenteropancreatic neuroendocrine tumors are a heterogeneous group of low incidence neoplasms characterized by a low proliferative activity and slow growth. Their response to targeted therapies is heterogeneous and often does not lead to tumor shrinkage. Thus, evaluation of the therapeutic response should differ from other kind of tumors.Methods:
To answer relevant questions about which techniques are best in the assessment of progression or treatment response a RAND/UCLA-based consensus process was implemented. Relevant clinical questions were listed followed by a systematic search of the literature. The expert panel answered all questions with recommendations, combining available evidence and expert opinion. Recommendations were validated through a questionnaire and a participatory meeting.Results:
Expert recommendations regarding imaging tools for tumor assessment and evaluation of progression were agreed upon. Available imaging techniques were reviewed and recommendations for best patient monitoring practice and the best way to evaluate treatment response were formulatedRESUMEN
No disponible
Texto completo:
1
Colección:
06-national
/
ES
Base de datos:
IBECS
Asunto principal:
Neoplasias Pancreáticas
/
Tumores Neuroendocrinos
/
Neoplasias Gastrointestinales
Tipo de estudio:
Diagnostic_studies
/
Guideline
/
Prognostic_studies
Límite:
Humans
Idioma:
En
Revista:
Clin. transl. oncol. (Print)
Año:
2018
Tipo del documento:
Article